Navigation Links
Sanofi-aventis Announces Non-Binding Offer to Acquire Genzyme
Date:8/29/2010

Monday, August 30, 2010 at 8:30 a.m. ET / 2:30 p.m. CET to discuss the proposal.  Those wishing to listen and participate should dial one of the following numbers:France:

+33-(0)1-72-00-13-68UK:

+44-(0) 203-367-94-53US:

+1-866-907-59-23Below is the full text of the letter sent today.

August 29, 2010

VIA EMAIL, TELECOPIER AND DHL

Mr. Henri A. Termeer

Chairman, President and Chief Executive Officer

Genzyme Corporation

500 Kendall Street

Cambridge, Massachusetts 02142

USA

Dear Henri

As you are aware, I have been trying to engage with you regarding a potential acquisition for the past few months.  As a consequence of your unwillingness even to meet with us, we sent you a detailed, written proposal on July 29, 2010.  We believe that this proposal to acquire all of the issued and outstanding shares of Genzyme for $69.00 per share in cash is compelling for Genzyme's shareholders and represents substantial value for them.  

We are disappointed that you rejected our proposal on August 11 without discussing its substance with us.   After our repeated requests, you agreed only to let our respective financial advisors hold a meeting of limited scope.  Our financial advisors finally met briefly on August 24, but the meeting simply served as further confirmation that as throughout you remain unwilling to have constructive discussions.  As I have mentioned to you, we are committed to a transaction with Genzyme, and, therefore, we feel we are left with no choice but to take our compelling proposal directly to your shareholders by making its terms public.

Sanofi-Aventis' fully-financed, all-cash offer to acquire all of the issued and outstanding shares of Genzyme's common stock for $69.00 per share represents a very significant premium of 38% over Genzyme's unaffected share price of $49.86 on July 1, 2010.  Our offer also represe
'/>"/>

SOURCE Sanofi-aventis
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Sanofi-Aventis and Novalar File Marketing Authorization Application for OraVerse® in Five Key European Countries
2. Oramed Pharmaceuticals and sanofi-aventis Enter Into an Agreement for the Insulin Supply of Orameds Oral Insulin Capsules
3. Sanofi-aventis Successfully Completes The Acquisition of Chattem, Inc.
4. Sanofi-aventis Successfully Completes Tender Offer for Chattem, Inc.
5. Sanofi-aventis Obtains Antitrust Clearance in Connection With Chattem, Inc. Tender Offer
6. Sanofi-aventis Commences Tender Offer for All Outstanding Shares of Chattem, Inc.
7. Sanofi-aventis to Acquire Chattem Inc., Creating a Strong U.S. Consumer Healthcare Platform
8. Intelliject, Inc. Enters Into Licensing Agreement with sanofi-aventis for U.S./Canada Rights to Novel Epinephrine Auto-injector
9. Sanofi-aventis U.S. and Intelliject, Inc. Sign Licensing Agreement for Novel Epinephrine Auto Injector in North America
10. Sanofi-aventis: Multaq(R) Approved in the European Union for Patients With Atrial Fibrillation
11. Sanofi-aventis and Regeneron Expand Strategic Antibody Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... than fifty years ago, Thalidomide was approved by Health Canada ... Thalidomide caused serious and permanent physical and emotional damage to ... provided to survivors over the years from sources including payments ... 1991 and settlements from drug companies. Even ... we have a clear moral obligation to help meet the ...
(Date:5/22/2015)... 2015 Electrophysiologist Kevin Makati, M.D. with ... Boston, MA to speak ... Rhythm Society conference. These scientific sessions drew more ... ideas, people and technology that propel their specialty ... minimally invasive cardiac operation that combines the expertise ...
(Date:5/22/2015)... May 22, 2015  The U.S. Food and ... -- the first biosimilar product approved in ... toward growth in the contract manufacturing organization (CMO) ... industry is geared to the production of small-molecular ... biopharmaceutical products. The healthcare market research publisher,s report, ...
Breaking Medicine Technology:Statement from Minister Ambrose on Thalidomide 2Statement from Minister Ambrose on Thalidomide 3St. Joseph's Hospital Heart Institute Physician Presents at Heart Rhythm Society 2St. Joseph's Hospital Heart Institute Physician Presents at Heart Rhythm Society 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 4
... 9, 2011 Lpath, Inc. (OTC: LPTN), the category ... 5th RetailInvestorConferences.com presentation is available for on-demand viewing. ... "register/ watch event now" button. Lpath, Inc.,s ... may download shareholder materials from the "virtual trade booth" ...
... Tenn., May 9, 2011 Muenster Memorial Hospital, ... serving a bi-county area north of Denton, Texas, ... Record as Muenster,s EMR solution, Michael Kent, Muenster ... ) (Logo: http://photos.prnewswire.com/prnh/20110503/CL93887LOGO-b ) ...
Cached Medicine Technology:Lpath, Inc. CEO Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com 2Lpath, Inc. CEO Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com 3Muenster Memorial Hospital Selects ChartSmart emr® 2Muenster Memorial Hospital Selects ChartSmart emr® 3
(Date:5/24/2015)... Indiana Fiber Network, LLC (IFN), the leading ... America, Inc. (MTA) has selected IFN as a fiber ... Enterprise Sales Manager, fiber route diversity and network redundancy ... provides MTA with the diverse fiber transport from their ... and voice carriers located at Henry Street in Indianapolis, ...
(Date:5/24/2015)... A report out just last month ... option for avoiding cardiovascular disease is exercise and maintaining ... single most powerful predictor of death and survival, even ... family history of premature death -- a finding that ... fitness. , The Importance of Cardiovascular Screening , The ...
(Date:5/23/2015)... 2015 Dr. David Benvenuti, an experienced plastic ... a new article to his website that takes ... Benvenuti explained in the fascinating blog, he has recently ... earlobes. , Known as “gauging,” the technique involves placing larger ... Benvenuti said will eventually stretch the holes out to incredible ...
(Date:5/23/2015)... On May 16, the team at ... a 5k mud obstacle run that raised funds for multiple ... worldwide, and the reason we participated was to support people ... of Farrell’s eXtreme Bodyshaping. “One-hundred percent of the funds raised ... event was not only attended by eXtreme Bodyshaping staff, but ...
(Date:5/23/2015)... Javon Bea Mercy Health System CEO ... Rehabilitation Center, 557 N. Washington St., Janesville, will host ... 5:30-6:30 pm. , The 8-week clinic is lead by ... BSN, who will offer training that encompasses a warm-up, ... and show selection and weekly training plans. , The ...
Breaking Medicine News(10 mins):Health News:Indiana Fiber Network, LLC Enables Midwest Telecom of America with Fiber Route Diversity 2Health News:Recent Mayo Clinic Studies Help to Highlight the Value of Cardio Testing 2Health News:Recent Mayo Clinic Studies Help to Highlight the Value of Cardio Testing 3Health News:Dr. Benvenuti, a Plastic Surgeon in Newport Beach, CA, Posts New Article about Repairing Ear Gauges 2Health News:Farrell’s eXtreme Bodyshaping Team Runs through the Muck for MS 2
... Peninsula College of Medicine and Dentistry (PCMD), University of ... and cost-effective strategy to screen people with type 2 ... the disease once every two years instead of annually. ... National Institute for Health Research Peninsula Collaboration for Leadership ...
... Adults and children should be screened routinely for changes in ... Medical Center researchers point out that regular visits to the ... because they can provide clues as to what,s going on ... in five Americans will develop some form of skin cancer ...
... FRIDAY, May 4 (HealthDay News) -- Patients with mental health ... a day -- in hospital emergency departments, and those who ... study says. Overall, patients with psychiatric emergencies wait about ... according to the findings published online May 1 in the ...
... additional imaging about 30% of the time in oncologic ... unnecessary, a new study shows. , The study, conducted ... patients. The study found that there were 84 ... examined the patients, records, they concluded that 43 of ...
... HealthDay Reporter , THURSDAY, May 3 (HealthDay ... evidence that regardless of how "full" a person may ... by overeating when tempted by yummy foods. The ... just eight participants, and the authors acknowledge that their ...
... , THURSDAY, May 3 (HealthDay News) -- New ... a significant role in a major advance in human brain ... SRGAP2 gene has been duplicated at least twice during human ... 2.5 million years ago. The second duplication produced only a ...
Cached Medicine News:Health News:Diabetic retinopathy research could reduce screening costs 2Health News:Doctors Urge Routine Skin Screenings 2Health News:Psychiatric Patients Often Wait Nearly 12 Hours in ER 2Health News:Why You Overeat Even When You're Full 2Health News:Why You Overeat Even When You're Full 3Health News:New Clues to the Evolution of the Human Brain 2
... The Stellate Harmonie workstation is a ... processing loads, high quality video capability, and ... recording and review functions A framework that ... and archiving of data A centralized database ...
... the capability to acquire images in near-real ... Brightness and Contrast levels, Auto-windowing, Image Manipulation, ... Rhodium spectrum which is best adapted to ... Revolution flat panel digital detector, which is ...
... The P3000 heralds a new concept in ... binocular infrared optical system developed for the P2000. ... standard in which we have paid particular attention ... Our new system is extremely flexible, allowing ...
... Foramen ovale electrodes typically are ... and are positioned on the ... lobe. The ultra-thin 1.0 mm ... firm enough to allow guidance ...
Medicine Products: